Farydak
Used for Multiple Myeloma
Used for Multiple Myeloma
Farydak (panobinostat) is a medication that's taken by mouth for the treatment of multiple myeloma (a type of bone marrow cancer). It was initially approved to be a part of a treatment that also included Velcade (bortezomib) and dexamethasone (Taperdex). It was only to be used by certain people for whom previous chemotherapy treatments didn't work well. Farydak (panobinostat) has been discontinued by the manufacturer and is no longer available in the United States.
What is Farydak (panobinostat)?
What is Farydak (panobinostat) used for?
- Multiple myeloma
Drug facts
| Common Brands | Farydak |
|---|---|
| Drug Class | Histone deacetylase inhibitor |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Discontinued |
Farydak (panobinostat) dosage
Typical dosage for Farydak (panobinostat)
What are alternatives to Farydak (panobinostat)?
There are a number of medications that your doctor can prescribe in place of Farydak (panobinostat). Compare a few possible alternatives below.
